Armata Pharmaceuticals, Inc. (ARMP) is a biotechnology company focused on developing novel therapeutic options targeting infectious diseases and resistant microorganisms. The company specializes in the use of phage therapy, a method that utilizes bacteriophages, natural predators of bacteria, to combat infections. This innovative technology could offer an alternative to traditional antibiotics, especially in cases of antibiotic resistance. Armata Pharmaceuticals aims to address the challenge of microbial resistance and the need for new treatment approaches. Investors interested in advancements in the treatment of infectious diseases and novel approaches to antibiotic resistance may see potential in Armata Pharmaceuticals, Inc. (ARMP) shares for innovation in the medical industry and improved patient care.